This research and development facility, being offered through a Chapter 11 bankruptcy sale, is purpose-built for preclinical CRO services and is being sold with lab equipment and intellectual property. Designed to support pharmaceutical, biotechnology and medical device development, the property is ideally suited for companies seeking a turnkey solution for regulated, high-complexity research.
